MAPT and early-onset autosomal dominant Alzheimer disease: Aβ42/Aβ40 and APP669-711/Aβ42 are recognized as biomarkers indicative of brain amyloidosis, whereas tau signify acute neuronal injury and is not specific biomarkers of Alzheimer’s disease [24].